Literature DB >> 22882693

Multidrug-resistant Klebsiella pneumoniae acquisition in lung transplant recipients.

Yael Raviv1, David Shitrit, Anat Amital, Benjamin Fox, Ilana Bakal, Renana Tauber, Jihad Bishara, Mordechai R Kramer.   

Abstract

BACKGROUND: Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a pathogen that emerged in the late twentieth century and was associated with significant morbidity and mortality. We report for the first time the outcomes of lung transplant recipients infected with CRKP or extended spectrum-β lactamases K. pneumoniae (ESBL-KP).
METHODS: Retrospective review of 136 lung transplant recipients who underwent transplantation between 2004 and 2007 in Rabin Medical Center, Israel. MAIN
RESULTS: There were 52 episodes of positive cultures for K. pneumoniae (KP) in 136 recipients - of them 11 (8.1%) with CRKP, 12 (8.8%) with ESBL-KP, and 29 (21.3%) with carbapenem-sensitive ESBL-negative KP. Isolation of CRKP/ESBL-KP was associated with death in the cohort (p < 0.0001) as well as recipients' age at transplantation (p < 0.005). Time-dependent age-adjusted CRKP or ESBL-KP acquisition was an independent factor for death in patients after lung transplant, compared to patients without KP isolation or carbapenem-sensitive ESBL-negative KP (p < 0.0001).
CONCLUSION: CRKP and KP-ESBL acquisition was associated with reduced survival among lung transplant recipients.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22882693     DOI: 10.1111/j.1399-0012.2012.01671.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  7 in total

Review 1.  Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.

Authors:  Stephanie M Pouch; Michael J Satlin
Journal:  Virulence       Date:  2016-07-28       Impact factor: 5.882

2.  Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.

Authors:  Kyle D Brizendine; Sandra S Richter; Eric D Cober; David van Duin
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

3.  The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.

Authors:  Michael J Satlin; Stephen G Jenkins; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2014-01-23       Impact factor: 9.079

Review 4.  Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.

Authors:  Guilherme Santoro-Lopes; Erika Ferraz de Gouvêa
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

5.  Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study.

Authors:  Simone Lanini; Alessandro Nanni Costa; Vincenzo Puro; Francesco Procaccio; Paolo Antonio Grossi; Francesca Vespasiano; Andrea Ricci; Sergio Vesconi; Michael G Ison; Yehuda Carmeli; Giuseppe Ippolito
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

6.  Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.

Authors:  Haiyang Meng; Lu Han; Mengxia Niu; Lu Xu; Min Xu; Qi An; Jingli Lu
Journal:  Infect Drug Resist       Date:  2022-08-04       Impact factor: 4.177

7.  Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis.

Authors:  Parichehr Shamsrizi; Beryl Primrose Gladstone; Elena Carrara; Dora Luise; Andrea Cona; Chiara Bovo; Evelina Tacconelli
Journal:  BMJ Open       Date:  2020-01-20       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.